Lee's Pharmaceutical Holdings Balance Sheet Health
Financial Health criteria checks 5/6
Lee's Pharmaceutical Holdings has a total shareholder equity of HK$1.6B and total debt of HK$231.5M, which brings its debt-to-equity ratio to 14.2%. Its total assets and total liabilities are HK$2.5B and HK$921.4M respectively. Lee's Pharmaceutical Holdings's EBIT is HK$70.7M making its interest coverage ratio 6.5. It has cash and short-term investments of HK$195.0M.
Key information
14.2%
Debt to equity ratio
HK$231.47m
Debt
| Interest coverage ratio | 6.5x |
| Cash | HK$194.99m |
| Equity | HK$1.63b |
| Total liabilities | HK$921.43m |
| Total assets | HK$2.55b |
Recent financial health updates
Recent updates
Lee's Pharmaceutical Holdings' (HKG:950) Earnings Are Weaker Than They Seem
Sep 04
There's Reason For Concern Over Lee's Pharmaceutical Holdings Limited's (HKG:950) Price
Aug 07Lee's Pharmaceutical Holdings (HKG:950) Has Affirmed Its Dividend Of HK$0.01
May 21Optimistic Investors Push Lee's Pharmaceutical Holdings Limited (HKG:950) Shares Up 28% But Growth Is Lacking
Dec 20Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01
May 21Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01
Apr 02Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01
Aug 29Does Lee's Pharmaceutical Holdings (HKG:950) Have A Healthy Balance Sheet?
Apr 05Can Mixed Fundamentals Have A Negative Impact on Lee's Pharmaceutical Holdings Limited (HKG:950) Current Share Price Momentum?
Mar 17Should You Buy Lee's Pharmaceutical Holdings Limited (HKG:950) For Its 0.9% Dividend?
Feb 22What Type Of Returns Would Lee's Pharmaceutical Holdings'(HKG:950) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Jan 29Financial Position Analysis
Short Term Liabilities: 950's short term assets (HK$696.8M) exceed its short term liabilities (HK$632.6M).
Long Term Liabilities: 950's short term assets (HK$696.8M) exceed its long term liabilities (HK$288.8M).
Debt to Equity History and Analysis
Debt Level: 950's net debt to equity ratio (2.2%) is considered satisfactory.
Reducing Debt: 950's debt to equity ratio has increased from 5.4% to 14.2% over the past 5 years.
Debt Coverage: 950's debt is well covered by operating cash flow (56.2%).
Interest Coverage: 950's interest payments on its debt are well covered by EBIT (6.5x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/15 12:28 |
| End of Day Share Price | 2025/02/14 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Lee's Pharmaceutical Holdings Limited is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jason Cheng | 3V Capital Limited |
| Yue-Kwong Lui | BOCOM International Securities Limited |
| Chu Wang | Citigroup Inc |